Cranston, RI, United States of America

Michael Leclerc

USPTO Granted Patents = 7 


 

Average Co-Inventor Count = 6.3

ph-index = 3

Forward Citations = 91(Granted Patents)


Company Filing History:


Years Active: 2015-2025

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Michael Leclerc in Nasal Delivery Devices**

Introduction

Michael Leclerc, an accomplished inventor based in Cranston, Rhode Island, holds a remarkable portfolio of six patents, primarily focused on enhancing nasal delivery devices. His innovations play a significant role in transforming how substances are delivered to the nasal airway of subjects, showcasing his dedication to advancing medical technology.

Latest Patents

Among his latest contributions are two patents for a nasal delivery device that presents a novel method of delivering substances efficiently. The device features a nosepiece designed to fit snugly within the nasal cavity and a mouthpiece for exhalation by the subject. It comprises a delivery unit that includes a manually displaceable actuation part to dispense substances from the nosepiece. Additionally, the device is equipped with a sophisticated valve assembly, allowing for streamlined airflow through the nosepiece while delivering the intended substance, which marks a significant improvement in user experience and efficacy.

Career Highlights

Michael Leclerc has made notable strides in the field of medical innovation, particularly within his role at Optinose AS. His expertise in the design and functionality of nasal delivery systems has established him as a pivotal figure in the industry. With six patents to his name, he continues to push the boundaries of what is possible in the realm of nasal delivery technology.

Collaborations

Throughout his career, Leclerc has collaborated with esteemed colleagues, including Per Gisle Djupesland and Joseph M. Gordon. Their combined expertise has resulted in advancements that enhance the practicality and effectiveness of nasal delivery devices, contributing to the growing body of knowledge in this essential field.

Conclusion

Michael Leclerc's contributions to the innovation of nasal delivery devices have positioned him as a key inventor in the pharmaceutical landscape. His patents reflect a commitment to improving delivery methods and user experience, making significant strides in how medicines are administered. With continued collaboration and innovation, he is poised to have a lasting impact on the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…